Alex Abelson

Cooley advised Odeko, a mobile ordering and supply chain management software for coffee shops and cafés, on its $126 million Series E financing round. Lawyers Tamim Bazzi, Alex Abelson, Christopher Nickas and Sophie Kraff led the Cooley team advising Odeko.

Cooley advised Windward Bio, a clinical-stage drug development company committed to improving outcomes for people living with advanced immunological diseases, on its $200 million Series A financing round. Partners Brandon Fenn and Ryan Sansom led the Cooley team advising Windward Bio.

Cooley advised Questa Capital, a venture growth equity firm focused on later-stage companies across healthcare, as lead investor in the $27.6 million financing round of OSSIO. OSSIO is a medical device company focused on evolving orthopedic surgery with bio-integrative fixation technology. Partner Brandon Fenn led the Cooley team advising Questa Capital.

Cooley advised Alentis Therapeutics, a clinical-stage biotechnology company developing treatments for Claudin-1 positive tumors and organ fibrosis, on its $181.4 million oversubscribed Series D financing round. Partners Brandon Fenn and Ryan Sansom led the Cooley team advising Alentis Therapeutics.

Cooley advised Photon Health, a digital health platform designed to help patients manage their prescriptions, on its $9 million financing round. Notation and Flare Capital Partners led the round. Roy Moran, Alex Abelson, Steve Andersen and Rhea George led the Cooley team advising Photon.